Dear visitor, this is a machine-translated article. It makes perfect sense in its original language (Czech), and is fully backed by independent scientific literature. The translation, though, is far from perfect and takes patience and imagination, if you decide to read it.

Drobečková navigace

Compound K

Compound K, also the metabolite M1

It is the product of metabolism of protopanaxadiol panaxosides, eg gssd Rb 1 :

Compound K

R1 = -H
R2 = -Glc

  • According to Park2005ieg , Compound K has the ability to suppress the production of NO and prostaglandin E2 in macrophages (RAW264.7) activated lipopolysaccharides by limiting NO synthase 2 (NOS2) and cyclooxygenase 2 (PTGS2) as well as blocking their NF-κB transcription factor.
  • In a mouse model of inflammation caused by a typical carbohydrate (12-0-tetradecanoylphorbol-13-acetate, TPA) compound K suppressed swelling and prevented the induction of inducible NO synthase (NOS2 gene) and cycloxygenase (PTGS2 gene) by blocking the transcription factor NF-κB ( Lee2005ape ) .
  • Compound K has the ability to reduce the proliferation and angiogenic activity of endothelial (umbilical vein) human cells that normally occurs after their stimulation by fibroblast growth factor (BFGF). Compound K has been found to prevent phosphorylation of MAP kinase (MAPK11), cellular stress molecules that further phosphorylates ATF-2, Mac and MEF2 transcription factors. ( Jeong2010cib )
  • In the HUVEC model (human umbilical vein endothelial cells), compound K had inhibitory effects on vascular smooth muscle proliferation, expression of proliferation associated molecules (CDK2, cyclin E, CDK4, cyclin D1 ...) and processes associated with vascular inflammation , venous varices Veins , hemorrhoids , esophagus varices ) and atherosclerosis ( Park2013cai ).
  • Compound K as well as protopanaxatriol control the maturation of immune dendritic cells towards the T h 1 type (= cytotoxic immune response ). ( Takei2004dcm , Takei2008dcp )
  • Compound K, ginsenoside Rg 2 and protopanaxatriol aglycon act inhibitory to the neuronal form of nicotinic acetylcholine receptors (α3β4) and their effect is selectively affected by interaction with BSA protein (bovine albumin). ( Lee2003deb )
  • An in vitro model has been shown to counteract the development of arthritis . ( Choi2013jec )
  • The rat model had a protective effect against arthritis. ( Chen2014gmc )

| 1.9.2009